Sonidegib free base
To Order Contact us: lieven@wlsolutions.be
 Sonidegib |
||
| T1926-50mg | 50mg | Ask for price |
|
Description: Sonidegib |
||
Sonidegib |
||
| T1926-5mg | 5mg | Ask for price |
|
Description: Sonidegib |
||
 Sonidegib-D4 |
||
| ESS0500-10mg | 10 mg | EUR 700 |
|
Description: Erismodegib-d4; N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4′-(trifluoromethoxy)-1,1′-biphenyl]-3-carboxamide-d4; LDE 225-d4; NVP-LDE 225-d4; Odomzo-d4 |
||
 Sonidegib-d4 |
||
| HY-16582AS | Get quote | Ask for price |
|
Description: Sonidegib-d4 is a isotope of Sonidegib. Sonidegib is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively[1]. |
||
 Sonidegib phosphate |
||
| 100942 | 100.0mg | EUR 250 |
) Sonidegib (diphosphate) |
||
| HY-16582 | 100mg | EUR 154.76 |
|
Description: Sonidegib diphosphate (Erismodegib diphosphate) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively[1]. |
||
 Sonidegib diphosphate |
||
| T15727-10mg | 10mg | Ask for price |
|
Description: Sonidegib diphosphate |
||
Sonidegib diphosphate |
||
| T15727-1g | 1g | Ask for price |
|
Description: Sonidegib diphosphate |
||
Sonidegib diphosphate |
||
| T15727-1mg | 1mg | Ask for price |
|
Description: Sonidegib diphosphate |
||
Sonidegib diphosphate |
||
| T15727-50mg | 50mg | Ask for price |
|
Description: Sonidegib diphosphate |
||
Sonidegib diphosphate |
||
| T15727-5mg | 5mg | Ask for price |
|
Description: Sonidegib diphosphate |
||
) Sonidegib (LDE-225) |
||
| 205510 | 25.0mg | EUR 90 |
 Sonidegib metabolite M48 |
||
| HY-117229 | Get quote | Ask for price |
|
Description: Sonidegib metabolite M48 is the main circulating metabolite of Sonidegib. Sonidegib is a hedgehog pathway inhibitor. M48 showed a much longer Tmax (60 h) than Sonidegib[1]. |
||
) LDE225 (NVP-LDE225, Sonidegib) |
||
| MBS385025-100mg | 100mg | EUR 345 |
LDE225 (NVP-LDE225, Sonidegib) |
||
| MBS385025-10mg | 10mg | EUR 160 |
LDE225 (NVP-LDE225, Sonidegib) |
||
| MBS385025-1mLinDMSO | 1mL(inDMSO) | EUR 140 |
LDE225 (NVP-LDE225, Sonidegib) |
||
| MBS385025-50mg | 50mg | EUR 240 |
LDE225 (NVP-LDE225, Sonidegib) |
||
| MBS385025-5mg | 5mg | EUR 140 |
 Sonidegib Hydrazo Impurity-D8 |
||
| ESS0501-5mg | 5 mg | EUR 700 |
)) I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-10mg | 10mg | EUR 470 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-1mg | 1mg | EUR 210 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-25mg | 25mg | EUR 780 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-50mg | 50mg | EUR 1130 |
I-37 free base (2359690-13-2(free base)) |
||
| MBS5759495-5mg | 5mg | EUR 335 |
)) I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-10mg | 10mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-1g | 1g | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-1mg | 1mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-50mg | 50mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
I-37 free base( 2359690-13-2(free base)) |
||
| T8721L-5mg | 5mg | Ask for price |
|
Description: I-37 free base( 2359690-13-2(free base)) |
||
 EDC free base |
||
| GM6988 | 5g | EUR 116.06 |
 TMB free base |
||
| TB0954 | 1g | EUR 85.06 |
 S107 free base |
||
| 530577 | 100.0mg | EUR 750 |
 NG25 free base |
||
| 562503 | 5.0mg | EUR 485 |
) R406 (free base) |
||
| A5880-100 | 100 mg | EUR 800 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-25 | 25 mg | EUR 320 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-5 | 5 mg | EUR 80 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-5.1 | 10 mM (in 1mL DMSO) | EUR 148 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
R406 (free base) |
||
| A5880-S | Evaluation Sample | EUR 24 |
|
Description: Tyrosine Kinase|Spleen Tyrosine Kinase (Syk) |
||
) THZ1 (Free base) |
||
| 9664-25 | each | EUR 1227.6 |
THZ1 (Free base) |
||
| 9664-5 | each | EUR 352.8 |
 K201 free base |
||
| 414202 | 5.0mg | EUR 288 |
 FIPI free base |
||
| 407955 | 200.0mg | EUR 1050 |
) FIPI (free base) |
||
| B2372-25 | each | EUR 757.2 |
FIPI (free base) |
||
| B2372-5 | each | EUR 235.2 |
) R406(free base) |
||
| MBS131267-100mg | 100mg | EUR 1065 |
R406(free base) |
||
| MBS131267-500mg | 500mg | EUR 2775 |
) SIS3 (free base) |
||
| HY-100444 | 10 mg | EUR 1244.61 |
|
Description: SIS3 free base is a potent and selective inhibitor of Smad3 phosphorylation. SIS3 free base inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 free base does not affect the phosphorylation of Smad2[1]. |
||
R406 (free base) |
||
| HY-11108 | 10mM/1mL | EUR 465.38 |
|
Description: R406 free base is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. R406 free base reduces immune complex-mediated inflammation[1]. R406 free base also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)[2]. |
||
R406(free base) |
||
| E1KS1533 | 2mg | EUR 362.4 |
 R406 free base |
||
| MBS3606124-10mg | 10mg | EUR 305 |
R406 free base |
||
| MBS3606124-25mg | 25mg | EUR 405 |
R406 free base |
||
| MBS3606124-2mg | 2mg | EUR 235 |
R406 free base |
||
| MBS3606124-50mg | 50mg | EUR 620 |
R406 free base |
||
| MBS3606124-5mg | 5mg | EUR 260 |
 R788 free base |
||
| MBS3606474-10mg | 10mg | EUR 315 |
R788 free base |
||
| MBS3606474-25mg | 25mg | EUR 430 |
R788 free base |
||
| MBS3606474-2mg | 2mg | EUR 225 |
R788 free base |
||
| MBS3606474-5mg | 5mg | EUR 260 |
R788 free base |
||
| MBS3606474-5x25mg | 5x25mg | EUR 1620 |
 SIS3 free base |
||
| MBS5767611-5mg | 5mg | EUR 915 |
SIS3 free base |
||
| MBS5767611-5x5mg | 5x5mg | EUR 3970 |
R406 (free base) |
||
| MBS8506526-2mg | 2mg | EUR 440 |
R406 (free base) |
||
| MBS8506526-5x2mg | 5x2mg | EUR 1835 |
R406 free base |
||
| T2467-10mg | 10mg | Ask for price |
|
Description: R406 free base |
||
R406 free base |
||
| T2467-1g | 1g | Ask for price |
|
Description: R406 free base |
||
R406 free base |
||
| T2467-1mg | 1mg | Ask for price |
|
Description: R406 free base |
||
R406 free base |
||
| T2467-50mg | 50mg | Ask for price |
|
Description: R406 free base |
||
R406 free base |
||
| T2467-5mg | 5mg | Ask for price |
|
Description: R406 free base |
||
SIS3 free base |
||
| T12923-10mg | 10mg | Ask for price |
|
Description: SIS3 free base |
||
SIS3 free base |
||
| T12923-1g | 1g | Ask for price |
|
Description: SIS3 free base |
||
SIS3 free base |
||
| T12923-1mg | 1mg | Ask for price |
|
Description: SIS3 free base |
||
SIS3 free base |
||
| T12923-50mg | 50mg | Ask for price |
|
Description: SIS3 free base |
||
SIS3 free base |
||
| T12923-5mg | 5mg | Ask for price |
|
Description: SIS3 free base |
||
 ML355 free base |
||
| 533249 | 50.0mg | EUR 350 |
 ML241 free base |
||
| 406621 | 10.0mg | EUR 90 |
 MS023 free base |
||
| 407274 | 10.0mg | EUR 150 |
 LYS01 free base |
||
| 407398 | 10.0mg | EUR 150 |
 ML298 free base |
||
| 407464 | 5.0mg | EUR 240 |
 M2698 free base |
||
| 407496 | 200.0mg | EUR 2950 |
 AZ505 free base |
||
| 407948 | 5.0mg | EUR 150 |
) MA242 (free base) |
||
| HY-112816A | Get quote | Ask for price |
|
Description: MA242 free base is a specific dual inhibitor of MDM2 and NFAT1. MA242 free base directly binds both MDM2 and NFAT1 with high affinity, induces their protein degradation, and inhibits NFAT1-mediated transcription of MDM2. MA242 free base induces apoptosis in pancreatic cancer cell lines regardless of p53 status[1]. |
||
) YM158 (free base) |
||
| HY-U00355 | 1mg | EUR 2770.8 |
) YM543 (free base) |
||
| HY-122613 | Get quote | Ask for price |
|
Description: YM543 free base is a potent and orally active sodium-glucose cotransporter (SGLT) 2 inhibitor. YM543 free base reduces blood glucose levels. YM543 free base can be used in research of diabetes[1][2]. |
||
) M1069 (free base) |
||
| HY-148088A | Get quote | Ask for price |
|
Description: M1069 (free base) is a selective and orall active, dual A2A/A2B adenosine receptor antagonist with a selectivity of >100 fold against the A1 and A3 receptors. M1069 (free base) counteracts immune-suppressive mechanisms of adenosine, and exhibits anti-tumor activity[1][2][3]. |
||
 AM095 free base |
||
| MBS3840238-10mg | 10mg | EUR 230 |
AM095 free base |
||
| MBS3840238-25mg | 25mg | EUR 370 |
AM095 free base |
||
| MBS3840238-5mg | 5mg | EUR 190 |
AM095 free base |
||
| MBS3840238-5x25mg | 5x25mg | EUR 1655 |
 YM158 free base |
||
| MBS5766149-5mg | 5mg | EUR 915 |